Last year in the UK over 60,000 cancer patients enrolled on clinical trials aimed at improving cancer treatments and making them available to all.
A study of the symptoms of myeloproliferative neoplasms (MEASURE)
This study is looking at a new questionnaire to collect information about the symptoms of myeloproliferative neoplasms. Myeloproliferative neoplasms are a group of disorders of the
People with myeloproliferative neoplasms can have a range of symptoms that can affect different parts of their body. The study team have designed a new questionnaire to collect information about the symptoms people have.
The aim of this study is to find out how well this questionnaire works.
Who can enter
The researchers need 300 people to join the study.
You fill in a diary over 7 days around the time you start your new treatment. You must answer the questions on at least 1 day before starting your new treatment. It should take no more than 15 minutes each day. You can complete the diary at home and then hand it to your doctor at the next appointment. Or you can return the diary by post afterwards.
Between 3 months and 6 months later you will complete the diary again.
The questions will ask about any symptoms you have had.
There are no extra visits to the hospital if you take part.
There are no side effects if you take part.
How to join a clinical trial
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Deepti Radia
Guy's and St Thomas' NHS Foundation Trust
NIHR Clinical Research Network: Cancer